Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
Human papillomavirus (HPV)
Malaria
SAGE documentation
2022
Clear all
Type of publications
NITAG documentation
(12)
SAGE documentation
(8)
Systematic reviews (SYSVAC)
(37)
Topics
Evidence to recommendation table
(1)
GRADE table
(1)
Position paper
(2)
SAGE background document
(4)
Regions
Countries
Diseases
Human papillomavirus (HPV)
(2)
Malaria
(6)
COVID-19
(16)
Hepatitis A
(4)
Influenza
(2)
Mpox // Monkeypox
(4)
Publication date
2022
(8)
2018
(1)
2017
(10)
2016
(2)
2015
(3)
2014
(2)
2008
(1)
Target population
Available to download in languages
English (EN)
(8)
French (FR)
(1)
8 results found
2022
∙
SAGE
Should an off-label , permissive one-dose HPV vaccine schedule for use in routine and/or multi-age cohort (MAC) catch up strategies be recommended?
2022
∙
SAGE
Human papillomavirus vaccines: WHO position paper, December 2022
2022
∙
SAGE
Malaria vaccine: WHO position paper
2022
∙
SAGE
Full Evidence Report on the RTS,S/AS01 Malaria Vaccine
2022
∙
SAGE
GRADE and Evidence to Recommendation tables on RTS,S/AS01 malaria vaccine
2022
Health Utilisation Study (HUS) Round 2 - cross-country report on findings from the Primary Child Caregiver cohort sample
2022
∙
SAGE
Modelled public health impact and cost effectiveness estimates of RTS,S/AS01 malaria vaccine in perennial and seasonal settings (August 2021)
2022
∙
SAGE
Statistical report on the results of the RTS,S/AS01 Malaria Vaccine Pilot Evaluation 24 months after the vaccine was introduced (September 2021, v1.2)
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register